Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Biomarker Test Companies

Numerous companies specialize in the development and commercialization of biomarker tests, which are used for diagnosing, monitoring, and predicting the progression of various diseases. These tests play a critical role in improving patient outcomes and advancing personalized medicine.

*Disclaimer: List of key companies in no particular orderLatest biomarker tests Companies Update

July 2023: Quest Diagnostics introduced a biomarker test for prostate cancer with the goal of enhancing the precision of biopsy grading. The diagnosis and evaluation of patients with prostate cancer rely heavily on the correct interpretation and grading of tissue. It's possible, though, that appearance doesn't match reality when it comes to biology. However, this year, researchers in Australia claimed to have developed a panel that might "transform clinical practice" by identifying biomarkers that describe prostate cancer biology.

September 2023: Oxford BioDynamics, Plc, a biotechnology company developing precision medicine tests based on the EpiSwitch® 3D genomics platform, today announced validation of its EpiSwitch Prostate Screening (PSE) blood test in its US clinical laboratory, allowing men at risk for prostate cancer to immediately have access to its highly accurate PSE test. The PSA score and five epigenetic biomarkers are used together in the PSE test to determine whether or not prostate cancer is present. Patients whose PSE results indicate a low risk of cancer are not automatically referred for a destructive and invasive biopsy, but rather placed on active monitoring and retested at a later date. In all likelihood, a visit to a urologist would be required for therapy.

July 2023: LucentAD, a test to aid in the evaluation of patients experiencing cognitive symptoms consistent with the early signs of Alzheimer's disease (AD), was released by Quanterix Corporation, a company that fuels scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection. When used in conjunction with other diagnostic techniques, the LucentAD test will let doctors to rapidly and easily determine whether or not a patient has amyloid pathology typical of Alzheimer's disease.

List of biomarker tests Key companies in the market

Hoffmann-La Roche AG

Novartis AG

Pfizer Inc.

GlaxoSmithKline plc

GE Healthcare

Medtronic plc

Quest Diagnostics

Biomarker Test Market Highlights:

Biomarker Test Market Size

Biomarker Test Market Trends

Biomarker Test Market Analysis

Biomarker Test Market Share

Biomarker Test Market Highlights:

Biomarker Test Market Trends

Biomarker Test Market Analysis

Biomarker Test Market Share

Biomarker Test Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.